Sample records for KNOCHENMARK (bone marrow)
from WorldWideScience.org

Sample records 1 - 20 shown. Select sample records:



96

Comparison between antithymocyte globulin and alemtuzumab and the possible impact of KIR-ligand mismatch after dose-reduced conditioning and unrelated stem cell transplantation in patients with multiple myeloma

Kroger, N; Shaw, B; Iacobelli, S; Zabelina, T; Peggs, K; Shimoni, A; Nagler, A; Binder, T; Eiermann, T; Madrigal, A; Schwerdtfeger, R

We compared antithymocyte globulin (ATG) with alemtuzumab in 73 patients with multiple myeloma, who underwent reduced conditioning with melphalan/fludarabine, followed by allogencic stem cell transplantation from human leucocyte antigen-matched or -mismatched unrelated donors. The ATG group had more...

DRIVER (German)

97

Bone marrow cell gene expression and tissue construct assembly using octacalcium phosphate microscaffolds

Dr Matthew John German

Calcium phosphates have been widely used in bone and soft tissue applications and are of considerable interest as scaffold materials due to properties of osteoconduction resorbability and in some cases osteoinduction. These materials are microcrystalline and as such are processed using sintering sur...

DRIVER (German)

99

Azacitidine for treatment of patients with myelodysplastic syndromes (MDS): practical recommendations of the German MDS Study Group


Abstract Myelodysplastic syndromes (MDS) are a group of common bone marrow disorders characterized by ineffective hematopoiesis, peripheral cytopenias, and a substantial risk of progression to acute myeloid leukemia (AML). For many years, the main treatment option for MDS was best supportive...

DRIVER (German)